"It's actually pretty difficult to build an artificially intelligent machine," according to a top Google life scientist, who is more focused on iterative machine learning.
The Colorado Center for Personalized Medicine has allied with the tech giant as it begins to integrate genomic and clinical data.
The former commissioner of the US Food and Drug Administration, Robert Califf, is heading to Alphabet's Verily.
Thomas Insel has left his position at Verily, according to Stat News.
New Scientist wonders whether Verily's Baseline Project will be able to meet its aim of developing a picture of a healthy person.
Verily seeks to expand its Baseline Project to yield a picture of a healthy person, the Verge reports.
CNBC reports that Google's parent company is wooing researchers from the healthcare and life science fields.
The amount of cancer data being generated is driving researchers to develop artificial intelligence and deep machine-learning methods to help them keep up.
The food safety firm is using NGS testing and data analytics to create actionable information for retailers and manufacturers.
Organizations are pursuing various approaches to control mosquitos harboring dengue and Zika viruses, Technology Review reports.
The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.
A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.
Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.
In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.